Sign Up
OverviewAPI
Adial Pharmaceuticals exercises warrants for $3.5 million gross proceeds through the sale of 1,150,000 shares, intending to support corporate operations and advance AD04 for Alcohol Use Disorder. The offering is managed by H.C. Wainwright & Co., set to finalize by March 6, 2024.

Ask a question